ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3073

Non-Additive Interaction of the Glucokinase Regulatory Protein and APOBEC1 Complementation Factor Loci with Alcohol Consumption to Influence the Risk of Gout

Humaira Rasheed1, Lisa K. Stamp2, Nicola Dalbeth3 and Tony R. Merriman4, 1University of Engineering and Technology, Lahore, Pakistan, 2University of Otago, Christchurch, New Zealand, 3University of Auckland, Auckland, New Zealand, 4Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: alcohol use, Gout and uric acid

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Metabolic and Crystal Arthropathies I: Mechanisms of Disease

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Genome-wide association studies (GWAS) have identified loci associated with serum urate levels and the risk of gout. Some of these loci interact in a non-additive fashion with dietary exposures to influence the risk of gout. This study aimed to systematically investigate non-additive interaction between alcohol exposure and urate-associated loci for the risk of gout.

Methods: A total of 3,312 New Zealand European and Polynesian (Maori/Pacific) people with and without gout were genotyped for 28 urate-associated genetic variants and tested for non-additive interaction with alcohol exposure (none versus any intake) influencing the risk of gout. Publicly-available genotype and serum urate data from the Atherosclerosis Risk in Communities (ARIC) study and the Framingham Heart Study (FHS) (n=7,110 European subjects) were used to test for non-additive interaction between specific genetic variants and alcohol exposure for the risk of hyperuricaemia (HU). Multivariate-adjusted logistic regression was done including an interaction term. P<8.6×10-4 was the significance level after application of a correction factor of 58.

Results: Non-additive interaction of alcohol exposure with GCKR (rs780094) and A1CF (rs10821905) was observed in Europeans to influence the risk of gout (ORInteraction=0.28, P=1.5×10-4 and ORInteraction=0.29, P=1.4×10-4, respectively). There was evidence for interaction of A1CF with alcohol exposure in determining HU in the ARIC/FHS sample set (ORInteraction=0.60, P=0.018), but not for GCKR (ORInteraction=0.82, P=0.18). Analysis of genotype groups stratified by alcohol exposure revealed that at A1CF alcohol exposure suppressed the gout risk conferred by the A-positive genotype (ORNo Alcohol=2.21; ORAlcohol=0.93) (Table). At GCKR alcohol exposure eliminated the genetic effect on gout – the ORs for each genotype group were equivalent (ORT-=2.07; ORT+=2.39) (Table). In Polynesians there was no experiment-wide evidence for non-additive interaction with alcohol in the risk of gout for any locus (P>8.6×10-4). However at GCKR there was nominal evidence for interaction in a direction consistent with that observed in Europeans (ORInteraction=0.62, P=0.05). At the five urate transporter loci (SLC2A9, ABCG2, SLC17A1, SLC22A11, SLC22A12) there was little or no evidence of interaction with alcohol in determining the risk of gout, with nominal evidence only in Europeans at SLC17A1 (ORInteraction=0.46, PUncorrected=0.027).

Conclusion: We describe a novel non-additive interaction of alcohol exposure with GCKR (glycolytic gene) and A1CF (apolipoprotein B mRNA editing gene) to influence the risk of gout in Europeans. These data support the hypothesis that alcohol influences the risk of gout via glucose and apolipoprotein metabolism. Table. Alcohol intake and gout association in genotype-stratified groups in Europeans for A1CF and GCKR.

No Alcohol Intake

Any Alcohol Intake

Adj OR[95% CI]

P

Adj OR[95% CI]

P

A1CF

A-

1

1

1.47 [0.99-2.16]

0.054

A+

2.21 [1.24-3.93]

0.007

0.93 [0.61-1.43]

0.76

GCKR

T-

1

1

2.07 [1.24-3.47]

0.0050

T+

4.13 [2.35-7.26]

8.65E-07

2.39 [1.47-7.26]

0.00043

Adjusted for age, sex and BMI.


Disclosure: H. Rasheed, None; L. K. Stamp, None; N. Dalbeth, None; T. R. Merriman, None.

To cite this abstract in AMA style:

Rasheed H, Stamp LK, Dalbeth N, Merriman TR. Non-Additive Interaction of the Glucokinase Regulatory Protein and APOBEC1 Complementation Factor Loci with Alcohol Consumption to Influence the Risk of Gout [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/non-additive-interaction-of-the-glucokinase-regulatory-protein-and-apobec1-complementation-factor-loci-with-alcohol-consumption-to-influence-the-risk-of-gout/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-additive-interaction-of-the-glucokinase-regulatory-protein-and-apobec1-complementation-factor-loci-with-alcohol-consumption-to-influence-the-risk-of-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology